In recent years, it is suggested that metabolites closely related to AD such as Aβ, Apolipoprotein E (ApoE), and tau protein [45, 46] can be cleared through the paravascular pathway in addition to the classical way of clearance [6]. The gene discussed is MAPT; the disease is Alzheimer disease.